LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/HealthCare?src=hash" target="_blank"gt;#HealthCarelt;/agt;–The global cancer stem cell therapeutics market is expected to post a
CAGR of close to 11% during the period 2019-2023, according to the
latest market research report by Technavio.
A key factor driving the growth of the global cancer stem cell
therapeutics market is the strong pipeline of novel cancer stem cell
therapies. The rising incidence of tumor recurrence, metastases, and the
increasing incidence of cancer are encouraging players in the market to
focus on the development of cancer stem cell therapeutics. Several drugs
in late-stage clinical trials are also expected to be launched during
the forecast period, which will drive the market growth. Moreover,
vendors in the market are increasingly focusing on developing cancer
therapeutics designed to inhibit cancer stemness pathways. Hence, with
the increasing number of trial therapies to be launched in the US by
2021, the demand for cancer stem cell therapeutics will rise
considerably in the forthcoming years.
As per Technavio, the availability of stem cell markers in the
identification of cancer stem cells will have a positive impact on the
market and contribute to its growth significantly over the forecast
period. This global
cancer stem cell therapeutics market 2019-2023
research report also analyzes other important trends and
market drivers that will affect market growth over 2019-2023.
Global cancer stem cell therapeutics market:
Availability of stem cell markers in identification of cancer stem cells
The availability of stem cell markers has eased the identification of
cancer stem cells in cervical cancer and breast cancer. Cervical cancer
is one of the most common types of cancer and is the leading cause of
death among women worldwide. Stem cell markers are increasingly being
used for the identification of cervical cancer stem cells. In addition,
cancer stem cells are increasingly becoming targets for cancer treatment
due to their capacity of self-renewal and tumorigenicity. Therefore,
with the rising use of stem cell markers, the identification of cancer
stem cells is increasing, which will boost the cancer stem cell
therapeutics market growth in the forthcoming years.
“The market is witnessing the development of first-in-class
therapeutics using induced pluripotent stem cells. These stem cells are
differentiated cells that are reprogrammed into an embryonic-like state
using nuclear programming. Induced pluripotent stem cells are widely
being implemented for the development of cancer stem cell therapeutics.
Such developments will lead to the growth of the market,” says a
senior research analyst at Technavio.
Global cancer stem cell therapeutics market:
Segmentation analysis
This market research report segments the global cancer stem cell
therapeutics market by type (allogenic stem cell transplant and
autologous stem cell transplant) and geographic regions (North America,
Europe, Asia, and ROW).
North America led the market in 2018, followed by Europe, Asia, and ROW
respectively. The market growth in North America can be attributed to
the growing prevalence of cancer in the US. Europe will account for the
fastest growth in the market due to the rising incidence of cancer
reported in the UK, Germany, and France.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com